T1	Participants 116 180	patients with previously untreated metastatic colorectal cancer.
T2	Participants 483 550	previously untreated metastatic colorectal carcinoma (CRC) patients
T3	Participants 686 698	380 patients
T4	Participants 986 1006	320 events assessed,
